Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported 2–10 band
Founded
2018
8 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
3
Grant · Jun 2023 · US$ 327.2K
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
CINCERA THERAPEUTICS PTY LTD
ABN50623119657
Legal entities
Show as table · Cincera Therapeutics Pty Ltd: 1 registry entity
| CINCERA THERAPEUTICS PTY LTD | ABN 50623119657 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Cincera Therapeutics is a privately held biotechnology company based in Melbourne, Australia. The company is focused on the discovery and development of new drugs aiming to treat difficult-to-treat inflammatory and fibrotic conditions associated with obesity/metabolic diseases, with potential applications in many other disease areas including cancer. The company will initially focus on treatments for the emerging epidemic of a liver disease termed ‘NASH’ (non-alcoholic steatohepatitis).
The Cincera team has developed novel drug like lead compounds that specifically inhibit a key enzymatic target in a lipid metabolism pathway. The novel and differentiated approach of Cincera is derived from the innovative research of its academic co-founders: medicinal chemist and entrepreneur Associate Professor Bernard Flynn, from the Monash Institute of Pharmaceutical Sciences (MIPS) at Monash University (Monash) in Melbourne, and lipid biologist Professor Stuart Pitson, from the Centre for Cancer Biology (CCB) at the University of South Australia (UniSA) in Adelaide.
The company is funded by the Medical Research Commercialisation Fund (MRCF), which is managed by the life science specialist venture capital management firm – Brandon Capital Partners (BCP).
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU31 Queen Street; Level 9,; Melbourne, VIC 3000Primary
Grid intelligence Members
Funding
Rounds3
Round typeGrant · non-equity funding
Amount (USD)327,200
Stage rank1
Investors named1
Since last round2 yr 7 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2018 to 2026 |
| Grant · 24 Jun 2023 | US$ 327.2K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
Which legal entity operates under Cincera Therapeutics Pty Ltd?
One Victoria entity on the ABR: CINCERA THERAPEUTICS PTY LTD (ABN 50 623 119 657), high confidence.
How many people work at Cincera Therapeutics Pty Ltd?
3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Cincera Therapeutics Pty Ltd have offices?
One address on record, Australia only. Primary: 31 Queen Street, Level 9, Melbourne, VIC 3000.
Has Cincera Therapeutics Pty Ltd raised funding?
Three rounds. Latest 24 June 2023: grant, US$327,200, investor Brandon BioCatalyst.
What does Cincera Therapeutics Pty Ltd list as its specialties?
One tag on the brand's own list, among them biotechnology.
Which companies are listed alongside Cincera Therapeutics Pty Ltd?
8 profiles list Cincera Therapeutics Pty Ltd as a peer — 76th percentile in Biotechnology Research. It lists ten peers of its own. Phrenix Therapeutics and Kraken Coding list it back.